Organigram Global Raises 2026 Revenue Guidance Following Acquisition of Sanity Group
Organigram Global Inc (NASDAQ:OGI) raised its full-year revenue guidance for 2026 to $350 million from $300 million, citing the contribution expected from newly acquired Germany-based cannabis company Sanity Group. The March quarter results showed a decline in net revenue and adjusted EBITDA due to weaker vape sales and production challenges.
Topics: acquisition impact cannabis industry CBD revenue guidance